Lyon: Ascend Stone Pharmaceutical Group (01093.HK) target price raised to 13.8 Hong Kong dollars with a "highly confident outperform market" rating.

Zh tng cijng APP hu xn, l'ng fb ynbo chng, sh yo jtun (01093.HK) jingsh diling cigu zhngc yuhu de zhyo shuy zh, ynwi hxn chnpn "n b p" min ln de diling cigu fngxin y df jingd, tngsh yu y mqin zhngc fng gng qngxing fy yyun gng du de chfng lngxng, ync yj yun yn yo j pnpi yo de shyngling jing df tshng. L'ng jing sh yo de mbio ji cng 12 gngyun shngtii zh 13.8 gngyun, giy "god quxn po yng dsh" pngj, bng jing 2026 zh 2027 nin shur ycng shngtii 1.4% j 6.8%, 2025 zh 2027 nin g nin chnl ycng y shngtii 1.6%, 1.2% j 4.8%.